Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.
Hsu
Yung-Hsuen
YH
Department of Nephrology, Taipei City Hospital, Jen-Ai Branch, Taipei, Taiwan, ROC.
Hsia
Ching-Chih
CC
Tsai
Dong-Ming
DM
Tu
Hsing-Yang
HY
Hung
Kuan-Yu
KY
Huang
Jenq-Wen
JW
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications* / Q000382:microbiology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008775:Methylprednisolone / Q000627:therapeutic use; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D056627:Peritoneal Fibrosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D010538:Peritonitis / Q000150:complications* / Q000382:microbiology; D013629:Tamoxifen / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D018931:Antineoplastic Agents, Hormonal; D005938:Glucocorticoids; D013629:Tamoxifen; D008775:Methylprednisolone